Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 31

Results For "patent"

337 News Found

Lifebit Biotech raises US $ 60 m in Series B funding
Startup | September 30, 2021

Lifebit Biotech raises US $ 60 m in Series B funding

Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success


UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches
Packaging | September 30, 2021

UFlex partners with Hoffer Plastics and Mespack to launch recyclable mono-polymer hot fill pouches

These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products


Flex Films launches F-UHB-M film to replace aluminium foil
Packaging | September 27, 2021

Flex Films launches F-UHB-M film to replace aluminium foil

A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant


Cosara Diagnostics receives CDSCO licence to manufacture Dengue test kit
Medical Device | September 17, 2021

Cosara Diagnostics receives CDSCO licence to manufacture Dengue test kit

It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.


Lupin to settle litigations over diabetes drug
News | September 16, 2021

Lupin to settle litigations over diabetes drug

The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval


Jharkhand to set up pharma park
Policy | September 15, 2021

Jharkhand to set up pharma park

The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi


US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma
Drug Approval | September 12, 2021

US FDA grants Soligenix Orphan Drug Designation for the treatment of T-cell lymphoma

Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma


Novavax initiates Phase 1/2 trials combining vaccine for Covid-19 and seasonal influenza
Biotech | September 09, 2021

Novavax initiates Phase 1/2 trials combining vaccine for Covid-19 and seasonal influenza

First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety


Equipment shortage and overpriced APIs pinch the pharma industry
News | September 09, 2021

Equipment shortage and overpriced APIs pinch the pharma industry

A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges


Sandoz enters agreement for oncology biosimilar medicine bevacizumab
Drug Approval | September 09, 2021

Sandoz enters agreement for oncology biosimilar medicine bevacizumab

Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems